Bioprocesses developed by Protéus benefit from the unsurpassed selectivity of the protein catalysts which make life possible. These catalysts are rapidly biodegraded when released in the environment and contain neither heavy metal nor any other toxic compound. In the hands of industrial chemists, such bio-catalysts enable to form enantiopure compounds, skip protection/deprotection steps and operate under mild conditions, hence forming lower amounts of undesired by-products.
Our focus is on providing quantum improvements of conversion yields, residence time, educts and products concentration, and energy consumption.
Protéus is a prominent player in white biotechnology for chemistry. Our flexible business model fits with the specific market constraints of our clients, whether in the fine, specialty or commodity chemicals sector. To better serve the pharmaceutical market, we created PCAS Biosolution a dedicated joint venture with European chemist PCAS to manufacture APIs and intermediates using routes which combine biocatalysis and chemistry
Download more about bio-based Chemistry at Protéus (pdf)